$50,000 of FORGE GLOBAL INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the treatment of certain retirement accounts. Issues related to investor access to equity in private companies. Issues related to tax treatment of certain retirement accounts."
You can find more data on corporate lobbying on Quiver Quantitative.
FRGE Insider Trading Activity
FRGE insiders have traded $FRGE stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $FRGE stock by insiders over the last 6 months:
- JENNIFER PHILLIPS (Chief Revenue & Growth Officer) has made 0 purchases and 6 sales selling 177,694 shares for an estimated $440,935.
- JAMES NEVIN (Chief Financial Officer) purchased 3,508 shares for an estimated $48,865
- KELLY RODRIQUES (Chief Executive Officer) sold 50,000 shares for an estimated $40,205
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FRGE Hedge Fund Activity
We have seen 30 institutional investors add shares of FRGE stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 7,690,567 shares (-93.4%) from their portfolio in Q1 2025, for an estimated $64,831,479
- VANGUARD GROUP INC removed 5,317,241 shares (-93.3%) from their portfolio in Q1 2025, for an estimated $44,824,341
- DOUGLASS WINTHROP ADVISORS, LLC added 4,153,167 shares (+1400.0%) to their portfolio in Q1 2025, for an estimated $35,011,197
- US BANCORP \DE\ removed 3,465,721 shares (-93.5%) from their portfolio in Q1 2025, for an estimated $29,216,028
- ALYESKA INVESTMENT GROUP, L.P. added 1,990,391 shares (+inf%) to their portfolio in Q1 2025, for an estimated $16,778,996
- ABACUS WEALTH PARTNERS, LLC removed 880,008 shares (-93.3%) from their portfolio in Q1 2025, for an estimated $7,418,467
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 814,044 shares (-92.5%) from their portfolio in Q1 2025, for an estimated $6,862,390
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FRGE Analyst Ratings
Wall Street analysts have issued reports on $FRGE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 05/12/2025
- JMP Securities issued a "Market Outperform" rating on 04/11/2025
To track analyst ratings and price targets for FRGE, check out Quiver Quantitative's $FRGE forecast page.
FRGE Price Targets
Multiple analysts have issued price targets for $FRGE recently. We have seen 3 analysts offer price targets for $FRGE in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Michael Cho from JP Morgan set a target price of $18.0 on 05/14/2025
- Richard Repetto from Piper Sandler set a target price of $30.0 on 05/12/2025
- Devin Ryan from JMP Securities set a target price of $60.0 on 04/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.